Have a feature idea you'd love to see implemented?
Let us know!
VANI Vivani Medical Inc
Price (delayed)
$1.275
Market cap
$70.45M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.46
Enterprise value
$64.23M
Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in
Highlights
The debt has decreased by 4.5% YoY
Vivani Medical's net income has decreased by 29% YoY but it has increased by 4.6% QoQ
The EPS is down by 18% year-on-year but it is up by 6% since the previous quarter
The equity has contracted by 26% YoY and by 17% from the previous quarter
The company's quick ratio fell by 10% QoQ and by 5% YoY
Key stats
What are the main financial stats of VANI
Market
Valuations
Earnings
Shares outstanding
55.26M
Market cap
$70.45M
Enterprise value
$64.23M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.94
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$24.2M
EBITDA
-$22.9M
Free cash flow
-$21.52M
Per share
Balance sheet
Liquidity
EPS
-$0.46
Free cash flow per share
-$0.39
Book value per share
$0.43
Revenue per share
$0
TBVPS
$0.88
Total assets
$48.22M
Total liabilities
$24.4M
Debt
$20.04M
Equity
$23.82M
Working capital
$20.55M
Debt to equity
0.84
Current ratio
4.55
Quick ratio
4.54
Net debt/EBITDA
0.27
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-48.1%
Return on equity
-97.3%
Return on invested capital
-63.4%
Return on capital employed
-57%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VANI stock price
How has the Vivani Medical stock price performed over time
Intraday
-1.16%
1 week
2.82%
1 month
5.37%
1 year
27.5%
YTD
25%
QTD
8.97%
Financial performance
How have Vivani Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.27M
Net income
-$24.2M
Gross margin
N/A
Net margin
N/A
Vivani Medical's net income has decreased by 29% YoY but it has increased by 4.6% QoQ
VANI's operating income is up by 6% YoY and by 5% QoQ
Growth
What is Vivani Medical's growth rate over time
Valuation
What is Vivani Medical stock price valuation
P/E
N/A
P/B
2.94
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is down by 18% year-on-year but it is up by 6% since the previous quarter
VANI's price to book (P/B) is 57% less than its 5-year quarterly average of 6.9 but 10% more than its last 4 quarters average of 2.7
The equity has contracted by 26% YoY and by 17% from the previous quarter
Efficiency
How efficient is Vivani Medical business performance
The return on equity has dropped by 116% year-on-year and by 3.6% since the previous quarter
Vivani Medical's return on invested capital has surged by 66% YoY and by 2.5% QoQ
The return on assets has declined by 37% year-on-year
Dividends
What is VANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VANI.
Financial health
How did Vivani Medical financials performed over time
The total assets is 98% more than the total liabilities
The total assets has contracted by 19% YoY and by 10% from the previous quarter
Vivani Medical's current ratio has decreased by 11% QoQ and by 11% YoY
The debt is 16% lower than the equity
VANI's debt to equity is up by 29% year-on-year and by 18% since the previous quarter
The equity has contracted by 26% YoY and by 17% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.